Discussion
A multimodal treatment approach that included off-label emicizumab, a drug approved for hemophilia A, stopped severe, hard-to-treat gastrointestinal bleeding in a 72-year-old woman with acquired…
Von Willebrand disease
Von Willebrand disease is a genetic bleeding disorder that impairs the body’s ability to form proper blood clots. It can cause frequent or prolonged bleeding episodes, but many people experience only mild or manageable symptoms.
Treatment for von Willebrand disease focuses on preventing and controlling bleeding to improve daily life and reduce serious risks. Management plans vary by disease type and may involve ongoing monitoring and personalized care strategies.
Latest news
Discussion
Discussion
HMB-002, an experimental antibody-based treatment from Hemab Therapeutics for von Willebrand disease (VWD), increased levels of von Willebrand factor (VWF) and improved measures…